# IBEX earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/IBEX) · [Earnings tab](https://www.lopjlb.com/stock/IBEX?tab=earnings) Updated: 2026-09-10T07:54:23 Quarters analyzed: 8 ## Cross-quarter narrative Across 8 calls for IBEX, management tone moved from -0.80 (2024 Q4) to +0.80 (2026 Q3). Latest guidance stance: raised. Latest desk line: Ibex posted record Q3 revenue and EPS growth, highlighted a 54% health‑tech surge, announced a strategic AI partnership with Sierra, raised full‑year guidance and emphasized sustainable, high‑margin growth. ## Latest CallCard · Q3 Ibex posted record Q3 revenue and EPS growth, highlighted a 54% health‑tech surge, announced a strategic AI partnership with Sierra, raised full‑year guidance and emphasized sustainable, high‑margin growth. **Guidance:** raised — Revenue guidance lifted to $638‑$642 million and adjusted EBITDA to $82‑$84 million for FY2026. **Tone:** mgmt 0.8 · Q&A pressure 0.4 · divergence 0.3 Management expressed confidence in momentum, record results and raised guidance, describing the business as future‑proofed and optimistic about AI and health‑tech growth. ### Demand visibility Strong demand across health‑tech, AI solutions and high‑margin verticals. Management cited robust health‑tech growth, rapid AI win velocity and continued client retention as drivers of demand visibility. ### Margins / costs Margin expansion expected from AI and higher‑margin services. BPO gross margins sit around 30% and AI/software margins are higher; SG&A fell to 16.7% of revenue, offset by a temporary near‑shore to offshore shift impact. ### Capital allocation Increased capex and continued share repurchases to fund growth. Capex raised to $25‑$30 million to expand capacity; repurchased ~140,000 shares; cash balance $15.4 million supports investments. ### Milestones - **Sierra AI partnership** [new]: Strategic partnership to deliver AI‑powered CX solutions, deemed transformative and accretive. - **HealthTech vertical expansion** [on_track]: Vertical grew 54% and is projected to exceed $100 million by fiscal year‑end. - **New logo wins Q1‑Q2 FY27** [new]: Added 3 significant wins in early April, total 11 YTD, fueling pipeline. - **AI solution early deployments** [on_track]: Early wins with airline and luxury brand delivered faster than competitors. - **Capacity adjustment for offshore shift** [at_risk]: Near‑shore to offshore move triggers an asset impairment charge in Q4. ### Fears / risks - **AI cannibalization**: Potential displacement of human‑agent volume by AI could erode traditional BPO revenue. - **Industry shrinkage perception**: Generative AI may reduce overall call‑center volumes, threatening BPO market size. - **Client concentration**: Largest client represents 9% of revenue; concentration risk remains. - **Telecom vertical decline**: Revenue exposure to telecom fell to 8.6% as legacy carrier volumes drop. - **Regulatory/tax changes**: Effective tax rate expected to rise to ~19% in Q4, affecting net margins. - **Execution risk on AI rollout**: Speed of AI solution deployment and integration with clients could face delays. - **Competitive pressure**: Other AI vendors and SaaS firms compete for the same AI‑CX contracts. - **Capacity impairment**: Shift of work to offshore may require write‑downs of assets, impacting earnings. ### Key quotes > “We delivered record revenue growth of 17% to $164.4 million, while adjusted EPS grew by 11% to $0.91.” > “We believe these solutions will be accretive to our business as we add on the AI volumes on top of our BPO business and create another vector for highly profitable revenue growth.” > “It does not impact at all. In fact, this gives us now the best-in-class engine with the best-in-class BPO.” > “None of that revenue was onetime in nature, Dave. It's all sustainable and this is the new run rate for health care.” — Taylor Greenwald ## Quarter one-liners - **2026 Q3:** Ibex posted record Q3 revenue and EPS growth, highlighted a 54% health‑tech surge, announced a strategic AI partnership with Sierra, raised full‑year guidance and emphasized sustainable, high‑margin growth. - **2026 Q2:** — - **2026 Q1:** IBEX delivered a record Q1 with 16.5% revenue growth and 74% EPS growth, raised FY2026 guidance, but flagged short‑term margin pressure from AI and offshore investments. - **2025 Q4:** IBEX delivered record FY25 revenue and earnings, expanded AI and offshore capabilities, entered India and raised FY26 guidance, while noting competitive AI pressures and higher SG&A costs. - **2025 Q3:** IBEX posted record Q3 FY2025 revenue of $140.7M, 11% growth, raised full-year guidance and launched a $15M share buyback while expanding into India and scaling AI solutions. - **2025 Q2:** — - **2025 Q1:** IBEX Q1 FY25: record revenue $129.7M (+4.1%), adj EBITDA margin 12% (+100bps), raised FY25 revenue guidance lower end to $515-525M, driven by new logo scaling and market share gains; AI wins expanding competitive moat. - **2024 Q4:** IBEX FY24: record EPS $2.10, EBITDA margin 14.4% in Q4, FCF $27M; revenue -2.8% YoY but Q4 inflection; 18 new clients, AI pipeline 40+ deals; FY25 margin guided to low 13%, targeting 15%; buybacks continue with $27M left; M&A evaluation underway. ## Theme arcs - **Management tone** (improving): Δ mgmt=+1.60 ## Fear persistence - **macroeconomic pressure** [resolved]: 2024 Q4 - **vertical concentration risk** [resolved]: 2024 Q4 - **wage inflation** [resolved]: 2024 Q4 - **ai adoption uncertainty** [resolved]: 2024 Q4 - **m&a integration risk** [resolved]: 2024 Q4 - **client concentration** [recurring]: 2025 Q3, 2025 Q4, 2026 Q1, 2026 Q3 - **competition from larger bpos** [resolved]: 2024 Q4 - **revenue growth inflection unproven** [resolved]: 2024 Q4 - **macro choppiness in base business** [resolved]: 2025 Q1 - **fintech vertical decline** [resolved]: 2025 Q1 ## Guidance path 2024 Q4:maintained → 2025 Q1:raised → 2025 Q2:vague → 2025 Q3:raised → 2025 Q4:maintained → 2026 Q1:raised → 2026 Q2:vague → 2026 Q3:raised --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/IBEX`